Third Avenue Management LLC Collegium Pharmaceutical, Inc Transaction History
Third Avenue Management LLC
- $506 Million
- Q3 2024
A detailed history of Third Avenue Management LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Third Avenue Management LLC holds 182,651 shares of COLL stock, worth $5.31 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
182,651
Previous 182,281
0.2%
Holding current value
$5.31 Million
Previous $5.87 Million
20.24%
% of portfolio
1.39%
Previous 1.2%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$168 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.6 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$75.3 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$68.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$48.1 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $992M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...